Network meta‐analysis and systematic review comparing efficacy and safety between very high power short duration, high power short duration, and conventional radiofrequency ablation of atrial fibrillation

High‐power short‐duration (HPSD) atrial fibrillation (AF) ablation with a power of 40–50 W was proved to be safe and effective. Very high‐power short‐duration (vHPSD) AF ablation is a novel method using >50 W to obtain more durable AF ablation. This study aimed to evaluate the efficacy and safety of vHPSD ablation compared with HPSD ablation and conventional power ablation.

[1]  H. Pürerfellner,et al.  Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data , 2022, Journal of cardiovascular development and disease.

[2]  M. Christoph,et al.  Reconnection patterns after CLOSE‐guided 50 W high‐power‐short‐duration circumferential pulmonary vein isolation and substrate modification—PV reconnection might no longer be an issue , 2022 .

[3]  G. Stabile,et al.  Safety and efficacy of very high-power short-duration ablation for pulmonary vein isolation , 2022, EP Europace.

[4]  B. Merkely,et al.  Impact of High-Power and Very High-Power Short-Duration Radiofrequency Ablation on Procedure Characteristics and First-Pass Isolation During Pulmonary Vein Isolation , 2022, Frontiers in Cardiovascular Medicine.

[5]  É. Marijon,et al.  90 vs 50-Watt Radiofrequency Applications for Pulmonary Vein Isolation: Experimental and Clinical Findings , 2022, Circulation. Arrhythmia and electrophysiology.

[6]  L. Lehmkuhl,et al.  Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF‐generator: Single‐center experience , 2022, Journal of cardiovascular electrophysiology.

[7]  P. Maurovich-Horvat,et al.  The effect of left atrial wall thickness and pulmonary vein sizes on the acute procedural success of atrial fibrillation ablation , 2022, The International Journal of Cardiovascular Imaging.

[8]  Y. Takeishi,et al.  Procedural characteristics of pulmonary vein isolation with high-power short-duration setting compared to conventional setting , 2022, BMC Cardiovascular Disorders.

[9]  Sean J Dikdan,et al.  High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation , 2021, Heart and Vessels.

[10]  B. Merkely,et al.  The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter—A pilot study , 2021, PloS one.

[11]  K. Okumura,et al.  Ablation Index-Guided High-Power Radiofrequency Application Shortens the Procedure Time With Similar Outcomes to Conventional Power Application in Atrial Fibrillation Ablation , 2021, Circulation reports.

[12]  K. Kuck,et al.  Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study , 2021, International journal of cardiology. Heart & vasculature.

[13]  Seil Oh,et al.  Acute and long‐term efficacy of ablation index‐guided higher power shorter duration ablation in patients with atrial fibrillation: A prospective registry , 2021, Journal of arrhythmia.

[14]  M. Christoph,et al.  Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high‐power short‐duration pulmonary vein isolation and substrate modification using the CLOSE protocol , 2021, Journal of cardiovascular electrophysiology.

[15]  Wei-feng Jiang,et al.  Meta-analysis of high power short duration in atrial fibrillation ablation – a superior efficient ablation strategy , 2021, Acta cardiologica.

[16]  K. Yokoyama,et al.  Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With High Power–Short Duration and Moderate Power–Moderate Duration: Effects of Thermal Latency and Contact Force on Lesion Formation , 2021, Circulation. Arrhythmia and electrophysiology.

[17]  P. Nery,et al.  High‐power, short‐duration atrial fibrillation ablation compared with a conventional approach: Outcomes and reconnection patterns , 2021, Journal of cardiovascular electrophysiology.

[18]  Sean J Dikdan,et al.  Comparison of clinical and procedural outcomes between high‐power short‐duration, standard‐power standard‐duration, and temperature‐controlled noncontact force guided ablation for atrial fibrillation , 2021, Journal of cardiovascular electrophysiology.

[19]  H. Calkins,et al.  Ablation outcomes for atypical atrial flutter versus recurrent atrial fibrillation following index pulmonary vein isolation , 2020, Journal of cardiovascular electrophysiology.

[20]  S. Knecht,et al.  Prospective Randomized Evaluation of High Power during CLOSE-guided Pulmonary Vein Isolation: The POWER-AF Study. , 2020, Circulation. Arrhythmia and electrophysiology.

[21]  Gordon H Guyatt,et al.  GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework , 2020, BMJ.

[22]  N. Akoum,et al.  High‐power short duration and low‐power long duration in atrial fibrillation ablation: A meta‐analysis , 2020, Journal of cardiovascular electrophysiology.

[23]  Lucas Luis Meigre,et al.  Changes and impacts in early recurrences after atrial fibrillation ablation in contact force era: comparison of high-power short-duration with conventional technique—FIRST experience data , 2020, Journal of Interventional Cardiac Electrophysiology.

[24]  J. Osorio,et al.  First pass isolation predicts clinical success after contact force guided paroxysmal atrial fibrillation ablation , 2020 .

[25]  Srinivas R. Dukkipati,et al.  High‐power short‐duration ablation of atrial fibrillation: A contemporary review , 2020, Pacing and clinical electrophysiology : PACE.

[26]  F. Sacher,et al.  Temperature and flow controlled ablation/very high-power short-duration ablation vs Conventional power-controlled ablation: Comparison of focal and linear lesion characteristics. , 2020, Heart rhythm.

[27]  Hong-Euy Lim,et al.  Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  C. Haffajee,et al.  Impact of High-Power Short-Duration Radiofrequency Ablation on Long-Term Lesion Durability for Atrial Fibrillation Ablation. , 2020, JACC. Clinical electrophysiology.

[29]  M. Shoda,et al.  Comparison of high‐power and conventional‐power radiofrequency energy deliveries in pulmonary vein isolation using unipolar signal modification as a local endpoint , 2020, Journal of cardiovascular electrophysiology.

[30]  S. Knecht,et al.  Evaluation of higher power delivery during RF pulmonary vein isolation using optimized and contiguous lesions , 2020, Journal of cardiovascular electrophysiology.

[31]  Shih‐Ann Chen,et al.  Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage? , 2020, Arrhythmia & electrophysiology review.

[32]  H. May,et al.  Long-term Outcomes After Low Power, Slower Movement versus High Power, Faster Movement Irrigated-Tip Catheter Ablation for Atrial Fibrillation. , 2020, Heart rhythm.

[33]  M. Shoda,et al.  Impedance drop predicts acute electrical reconnection of the pulmonary vein-left atrium after pulmonary vein isolation using short-duration high-power exposure , 2020, Journal of Interventional Cardiac Electrophysiology.

[34]  A. Buxton,et al.  Temperature-Controlled Radiofrequency Ablation Using Irrigated Catheters: Maximizing Ventricular Lesion Dimensions While Reducing Steam-Pop Formation. , 2020, JACC. Clinical electrophysiology.

[35]  F. Bourier,et al.  Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[36]  K. Okumura,et al.  High‐power application is associated with shorter procedure time and higher rate of first‐pass pulmonary vein isolation in ablation index‐guided atrial fibrillation ablation , 2019, Journal of cardiovascular electrophysiology.

[37]  H. Ichiki,et al.  Abstract 13136: First-Pass Isolation is Associated With Durability of Pulmonary Vein Isolation and Has Impact on Atrial Fibrillation Ablation Outcomes , 2019 .

[38]  J. Merino,et al.  Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study , 2019, Journal of Interventional Cardiac Electrophysiology.

[39]  F. Ruschitzka,et al.  Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter , 2019, Journal of cardiovascular electrophysiology.

[40]  Lucas Luis Meigre,et al.  Comparison of high‐power short‐duration (HPSD) ablation of atrial fibrillation using a contact force‐sensing catheter and conventional technique: Initial results , 2019, Journal of cardiovascular electrophysiology.

[41]  R. Winkle,et al.  Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations. , 2019, Heart rhythm.

[42]  Nicky J Welton,et al.  Automated methods to test connectedness and quantify indirectness of evidence in network meta‐analysis , 2018, Research synthesis methods.

[43]  Frederick T. Han,et al.  High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of Esophageal Injury. , 2018, JACC. Clinical electrophysiology.

[44]  Spyridon N Papageorgiou,et al.  Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. , 2018, Journal of clinical epidemiology.

[45]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[46]  Mohammad Hassan Murad,et al.  A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.

[47]  Anna Chaimani,et al.  Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.

[48]  Á. Gil,et al.  Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.

[49]  AE Ades,et al.  Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡ , 2012, Research synthesis methods.

[50]  T. Lewalter.  [Rhythm---control in atrial fibrillation]. , 2012, MMW Fortschritte der Medizin.

[51]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[52]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[53]  D. Tamborero,et al.  Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extension. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[54]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[55]  J. Svendsen,et al.  The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[56]  M. Hirai,et al.  Can segmental pulmonary vein ablation reduce the recurrence of atrial fibrillation when using a higher RF power, larger tip electrode catheter, and additional RF deliveries?: the limitations of point-by-point RF ablation. , 2006, International heart journal.

[57]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[58]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. , 2013 .